Medgenics receives orphan drug status for Hepatitis D treatment
Linkedin

Medgenics receives orphan drug status for Hepatitis D treatment

Rishon Le Zion : Israel | Jun 21, 2012 at 12:55 AM PDT
Source: Globes Online
XX XX
Views: Pending
 
Biopump for the treatment of Hepatitis D has received orphan drug status from the US Food and Drug Administration (FDA). Medgenics Biopump technology platform, which produces interferon alpha, commonly used to treat hepatitis. Medgenics said that this is the first orphan drug status granted for... FULL ARTICLE AT Globes Online
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.